A conversation with Kindeva Drug Delivery's Director and Bay Area Site Head, Keith Ung, about the 2022 acquisition of iPharma Labs Inc. by Kindeva and inhalation drug formulation.

A conversation with Kindeva Drug Delivery's Director and Bay Area Site Head, Keith Ung, about the 2022 acquisition of iPharma Labs Inc. by Kindeva and inhalation drug formulation.

A conversation with Kindeva Drug Delivery's Director and Bay Area Site Head, Keith Ung, about the 2022 acquisition of iPharma Labs Inc. by Kindeva and inhalation drug formulation.

A conversation with Kindeva Drug Delivery’s Louise Righton about the role of sustainability as it relates to pressurized metered-dose inhalers.

A conversation with Kindeva Drug Delivery’s Louise Righton about the role of sustainability as it relates to pressurized metered-dose inhalers.

A discussion with Laura Walsh and Tim Peterson about the science of skin and the role Kindeva technologies can play in helping deliver various APIs to and through the skin. The discussion is based on the brochure located here

A conversation with Kindeva Drug Delivery’s Dr. Ben Myatt about pressurized meter dose inhaler plume characterizations, specifically around alternative propellants temperature and pressure measurements.

A conversation with Kindeva Drug Delivery’s Dr. John Vasilakos about the role of microneedles in the delivery of cancer vaccines.

A conversation with Kindeva Drug Delivery’s CEO, Aaron Mann about the critical role of contract development manufacturing organizations